Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

ClinicalTrials.gov ID: NCT01168713

Public ClinicalTrials.gov record NCT01168713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Oral CEM-101 Compared to Oral Levofloxacin in the Treatment of Patients With Community-Acquired Bacterial Pneumonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to evaluate the safety and efficacy of oral CEM-101 compared to oral Levofloxacin in the treatment of adults with moderate to moderately severe community-acquired bacterial pneumonia.

Study identification

NCT ID
NCT01168713
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
132 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Jun 30, 2011
Completion
Jun 30, 2011
Last update posted
Mar 2, 2017

2010 – 2011

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
44
Facility City State ZIP Site status
Not listed Birmingham Alabama 35242
Not listed Flagstaff Arizona 86001
Not listed Bell Gardens California 90201
Not listed Chula Vista California 91911
Not listed LeMesa California 91942
Not listed Los Angeles California 90015
Not listed Montclaire California 91763
Not listed Norwalk California 90650
Not listed Oceanside California 92056
Not listed Oxnard California 93030
Not listed Pasadena California 91105
Not listed Torrence California 90501
Not listed Waterbury Connecticut 06708
Not listed DeBary Florida 32713
Not listed Gainesville Florida 32605
Not listed Hialeah Florida 33012
Not listed Kissimmee Florida 34741
Not listed Orlando Florida 32837
Not listed Blue Ridge Georgia 30513
Not listed Columbus Georgia 31904
Not listed Savannah Georgia 31406
Not listed Idaho Falls Idaho 83404
Not listed Morton Illinois 61550
Not listed Dubuque Iowa 52001
Not listed New Orleans Louisiana 70112
Not listed Fall River Massachusetts 02720
Not listed New Bedford Massachusetts 02740
Not listed Detroit Michigan 48202
Not listed Traverse City Michigan 49684
Not listed Butte Montana 59701
Not listed Las Vegas Nevada 89109
Not listed Akron Ohio 44304
Not listed Carlisle Ohio 45005
Not listed Eugene Oregon 97404
Not listed West Reading Pennsylvania 19611
Not listed Simpsonville South Carolina 29681
Not listed Rapid City South Dakota 57702
Not listed Franklin Tennessee 37067
Not listed Corsicana Texas 75110
Not listed Houston Texas 77002
Not listed Houston Texas 77093
Not listed San Antonio Texas 78238
Not listed Draper Utah 84020
Not listed Magna Utah 84044
Not listed Salt Lake City Utah 84121

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01168713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01168713 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →